| 1 |
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Köbel, Steve E. Kalloger, Niki Boyd et al. · PLoS Medicine
Open access |
26 Nov 2008 |
830 |
| 2 |
The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
Patrick O. Brown, Chana Palmer · PLoS Medicine
Open access |
27 Jul 2009 |
250 |
| 3 |
On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?
Laura Vallejo‐Torres, Borja García‐Lorenzo, Iván Castilla‐Rodríguez et al. · Value in Health
Open access |
30 Apr 2016 |
177 |
| 4 |
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized
Jesse K. McKenney et al. · The American Journal of Surgical Pathology
|
16 Sep 2016 |
135 |
| 5 |
The Potential Impact of Reproducibility of Gleason Grading in Men With Early Stage Prostate Cancer Managed by Active Surveillance: A Multi-Institutional Study
Jesse K. McKenney, Jeff P. Simko, Michael J. Bonham et al. · The Journal of Urology
|
23 Jun 2011 |
109 |
| 6 |
DNA Methylation Profiles of Ovarian Epithelial Carcinoma Tumors and Cell Lines
Sahar Houshdaran, Sarah T. Hawley, Chana Palmer et al. · PLoS ONE
Open access |
19 Feb 2010 |
103 |
| 7 |
Multiplex Targeted Proteomic Assay for Biomarker Detection in Plasma: A Pancreatic Cancer Biomarker Case Study
Sheng Pan, Ru Chen, Randall E. Brand et al. · Journal of Proteome Research
Open access |
8 Feb 2012 |
96 |
| 8 |
Mutation Analysis of BRAF, MEK1 and MEK2 in 15 Ovarian Cancer Cell Lines: Implications for Therapy
Anne L. Estep, Chana Palmer, Frank P. McCormick et al. · PLoS ONE
Open access |
4 Dec 2007 |
94 |
| 9 |
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
Tamara Levin Lotan et al. · Modern Pathology
Open access |
13 May 2016 |
93 |
| 10 |
Probabilistic Segmentation of Mass Spectrometry (MS) Images Helps Select Important Ions and Characterize Confidence in the Resulting Segments
Kyle D. Bemis, April J. Harry, Lívia S. Eberlin et al. · Molecular & Cellular Proteomics
Open access |
21 Jan 2016 |
89 |
| 11 |
Systematic Evaluation of Candidate Blood Markers for Detecting Ovarian Cancer
Chana Palmer, Xiaobo Duan, Sarah J. Hawley et al. · PLoS ONE
Open access |
9 Jul 2008 |
84 |
| 12 |
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer
Tamara Levin Lotan, Wei Wei, Carlos L. Morais et al. · European Urology Focus
Open access |
12 Aug 2015 |
76 |
| 13 |
Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies
Maria Tretiakova et al. · Prostate Cancer and Prostatic Diseases
Open access |
3 May 2016 |
68 |
| 14 |
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
Dean A. Troyer, Tamara Jamaspishvili, Wei Wei et al. · The Prostate
Open access |
4 May 2015 |
67 |
| 15 |
Ovarian Cancer Early Detection Claims Are Biased
Martin W. McIntosh, Garnet L. Anderson, Charles W. Drescher et al. · Clinical Cancer Research
|
24 Oct 2008 |
42 |
| 16 |
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for “large” cribriform prostatic adenocarcinoma
Emily Chan et al. · Modern Pathology
Open access |
10 Feb 2022 |
39 |
| 17 |
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage
Jane Nguyen et al. · Histopathology
Open access |
3 Jun 2024 |
35 |
| 18 |
Suicide Coverage in the Digital Press Media: Adherence to World Health Organization Guidelines and Effectiveness of Different Interventions Aimed at Media Professionals
Francisco J. Acosta, Carlos J. Rodríguez, María R. Cejas et al. · Health Communication
|
30 Aug 2019 |
32 |
| 19 |
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort
James D. Brooks et al. · The Prostate
Open access |
21 Jun 2016 |
30 |
| 20 |
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients
James D. Brooks, Wei Wei, Sarah J. Hawley et al. · PLoS ONE
Open access |
14 Jul 2015 |
29 |
| 21 |
A Model for the Design and Construction of a Resource for the Validation of Prognostic Prostate Cancer Biomarkers
Sarah J. Hawley et al. · Advances in Anatomic Pathology
Open access |
11 Dec 2012 |
28 |
| 22 |
Pilot Study of Blood Biomarker Candidates for Detection of Pancreatic Cancer
Ru Chen, David A. Crispin, Sheng Pan et al. · Pancreas
Open access |
13 May 2010 |
26 |
| 23 |
Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis
Samuel Francis Ruder et al. · Human Pathology
Open access |
14 Feb 2022 |
25 |
| 24 |
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study
Okyaz Eminağa, Wei Wei, Sarah J. Hawley et al. · PLoS ONE
Open access |
15 Nov 2016 |
25 |
| 25 |
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer
Debashis Sahoo, Wei Wei, Heidi J. Auman et al. · Oncotarget
Open access |
5 Jan 2018 |
24 |
| 26 |
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker
Shiqin Liu et al. · Scientific Reports
Open access |
4 Jan 2024 |
12 |
| 27 |
The accumulation of versican in the nodules of benign prostatic hyperplasia
Lawrence D. True, Sarah J. Hawley, Thomas H. Norwood et al. · The Prostate
Open access |
25 Sep 2008 |
12 |
| 28 |
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study
Palak G. Patel et al. · Modern Pathology
Open access |
19 Jun 2023 |
10 |
| 29 |
Characterizing Twitter Influencers in Radiation Oncology
Luca Valle, Fang‐I Chu, Marc A. Smith et al. · Advances in Radiation Oncology
Open access |
23 Mar 2022 |
9 |
| 30 |
Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube
Ian Beddows, Svetlana Djirackor, Dalia K. Omran et al. · Nature Communications
Open access |
26 Mar 2025 |
5 |
| 31 |
Prostate cancer risk stratification via non-destructive 3D pathology with annotation-free gland segmentation and analysis
Weisi Xie et al. · medRxiv
PreprintOpen access |
2 Sep 2021 |
3 |
| 32 |
Preliminary assessment of the degree of food addiction through the Spanish Yale Food Addiction Scale for Children (S-YFAS-C) in a pilot pediatric population.
Néstor Benítez Brito, Himar Pacheco González, Berta Pinto Robayna et al. · Research Square
PreprintOpen access |
28 Nov 2022 |
0 |
| 33 |
Deep Learning-assisted 3D Segmentation and Analysis of Prostate Glands for Cancer Risk Stratification
Weisi Xie et al.
Conference paper |
2022 |
0 |
| 34 |
PD20-02 CAN ACTIVE SURVEILLANCE REALLY REDUCE THE HARMS OF PSA TESTING, LIKE THE U.S. PREVENTATIVE SERVICES TASK FORCE CURRENTLY SUGGESTS? THE PRIAS-STUDY IMPLICATES CAUTION
F.-J. Drost, Antti Sakari Rannikko, Riccardo Valdagni et al. · The Journal of Urology
Open access |
Apr 2018 |
0 |